The SMAD4 mutation was associated with adenocarcinomas exhibiting mucinous morphology, which portends a poorer prognosis, while the most prevalent mutation of IDH1 is the R132C variant, which occurs in 20% of cases [17]. This evidence concerns the gene IDH1 and adenocarcinoma.